Pharmacological Management of Obesity
Tracking # 20-1266243
Course overview
After completing this activity, learners will be able to: 1. Understand the definitions, epidemiology, and risk factors associated with obesity, including genetic, environmental, and behavioral influences. 2. Explore the pathophysiology of obesity, focusing on energy balance, hormone regulation, and mechanisms of weight gain. 3. Discuss the health consequences of obesity, such as cardiovascular disease and diabetes, and review diagnostic criteria, including BMI and other measures. 4. Review pharmacological treatments for obesity, including Orlistat, Liraglutide, and combination therapies like Phentermine/Topiramate and Contrave. 5. Examine patient management considerations for obesity, including lifestyle interventions, adherence strategies, and monitoring for side effects of pharmacotherapy.
Subject areas
This course counts toward the state boards and subject areas below.
Arkansas State Board of Nursing
Registered Nurse Practitioner
District of Columbia Board of Nursing
Nurse Practitioner
Kansas State Board of Nursing
Nurse Practitioner
New Hampshire Board of Nursing
Advanced Practice Registered Nurse
North Dakota Board of Nursing
Advanced Practice Registered Nurse
South Carolina Board of Nursing
Advanced Practice Registered Nurse
Disclosure statements
eMedEd ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, eMedEd identifies conflicts of interest with its instructors, planners, content managers, and other individuals who can control an activity's content.
All faculty, planners, and/or content managers have nothing to disclose, nor do they have any vested interests or affiliations.